3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
9
Carcinoma, Renal Cell
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Kidney Neoplasms
3
Lymphoma
2
Leukemia
2
Skin Neoplasms
1
Sezary Syndrome
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neurofibromatosis 1
1
Neurofibroma, Plexiform
1
Neurofibroma
1
Neoplasms
1
Neoplasm Metastasis
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Leukemia-Lymphoma, Adult T-Cell
1
HTLV-I Infections
1
Glioma
1
Fallopian Tube Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Squamous Cell
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Brain Neoplasms
1
Astrocytoma
1
Interventions
fludarabine phosphate
15
Whole-Body Irradiation
9
Peripheral Blood Stem Cell Transplantation
9
Mycophenolic Acid
9
Cyclophosphamide
8
Busulfan
8
Tacrolimus
7
Cyclosporine
5
fludarabine
4
Methotrexate
4
Antilymphocyte Serum
4
ruxolitinib
3
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
3
peginterferon alfa-2a
2
givinostat hydrochloride
2
givinostat
2
Stem Cell Transplantation
2
Radiotherapy
2
Melphalan
2
Etoposide
2
Carboplatin
2
veliparib
1
thymoglobulin
1
sonidegib
1
pomalidomide
1
merphos
1
bomedemstat
1
anagrelide
1
Transplantation
1
Topotecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Thrombocythemia, Essential
×
peginterferon alfa-2b
×
Clear all
No trials found.